Raquel Fortunado, PhD

Gelbet Biopharmaceuticals

Raquel Fortunato is the CEO of GenIbet Biopharmaceuticals, a Portuguese CDMO offering highly specialized microbial, cell culture and viral GMP manufacturing services and process development to research groups, biotech and pharma companies.
Raquel is a Chemical Engineer from Instituto Superior Técnico (Lisbon – Portugal) with a specialization in Biotechnology, a PhD in Biochemical Engineering from the NOVA University of Lisbon and Post-graduate education in General Management (NOVA University of Lisbon).

Prior to joining GenIbet in 2006 as a Project Manager, she was the responsible for the launch of the Quality Control laboratory of a water treatment company. Raquel was GenIbet operations director from 2011 to 2015 and has expertise in Technology Transfer Processes, Project Management, Budget implementation, Technical Support to Process Operations, Client Interface, Quality Assurance and Team Coordination.